Patent details
LUC50015 Product Name: Niraparib or a pharmaceutically acceptable salt thereof in particular niraparib tosylate in particular niraparib tosylate monohydrate, optionally in combination with abiraterone in particular abiraterone acetate
Basic Information
- Publication number:
- LUC50015
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP177542263
- Legal Status:
- Pending & Published
- Application number:
- LUC50015
- First applicant's nationality:
- Procedural language:
- English
Marketing Authorization
- Marketing Authorization Number:
- EU/1/23/1722
- Marketing Authorization Type:
- Marketing Authorization Date:
- 20/04/2023
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 18/07/2025
- First Marketing Authorization date:
- 20/04/2023
- Grant date:
- Activation date:
- Publication date:
- 21/07/2025
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 20/04/2038
- SPC Extension Expiration:
- 20/04/2038
- Rejection date:
- Withdrawal date:
Owner
- From:
- 25/09/2025
- Name:
- Janssen Pharmaceutica NV
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
History of Owners
- From:
- 18/07/2025
- To:
- 25/09/2025
- Name:
- Janssen Pharmaceutica, N.V.
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
Agent
- Name:
- Dennemeyer & Associates S.A.
- From:
- 18/07/2025
- Address:
- 55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2025/09
- Publication date:
- 05/08/2025
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2025/12
- Publication date:
- 07/11/2025
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name/address
- Deed Number:
- RC20250000352A
- Date Registered:
- 25/09/2025
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- Dennemeyer & Associates S.A.
- Journal Edition Number:
- Text:
- changement de nom
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- Janssen Pharmaceutica NV
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/07/2037
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 18/07/2025 | General Document | 44 |
| 18/07/2025 | General Document | 116 |
| 21/07/2025 | Outgoing Correspondence | 1 |
| 18/07/2025 | Outgoing Correspondence | 3 |
| 18/07/2025 | General Document | 1 |
| 18/07/2025 | General Document | 24 |
| 18/07/2025 | General Document | 3 |
| 18/07/2025 | General Document | 24 |
| 18/07/2025 | General Document | 32 |
| 18/07/2025 | General Document | 1 |
| 18/07/2025 | General Document | 53 |
| 18/07/2025 | Application Form | 5 |
| 18/07/2025 | General Document | 59 |
| 21/07/2025 | Publication | 1 |
| 21/07/2025 | Outgoing Correspondence | 1 |
| 25/09/2025 | Outgoing Correspondence | 2 |
| 25/09/2025 | Incoming Correspondence (Email) | 2 |
| 25/09/2025 | General Document | 1 |
| 25/09/2025 | General Document | 1 |
| 16/09/2025 | Outgoing Correspondence | 2 |
| 16/09/2025 | General Document | 3 |
| 16/09/2025 | General Document | 1 |
| 16/09/2025 | Incoming Correspondence (Email) | 2 |
| 16/09/2025 | General Document | 1 |
| 25/09/2025 | Request For Change | 1 |
| 01/10/2025 | Outgoing Correspondence | 1 |